Preventive Nutrition and Food Science

The Korean Society of Food Science and Nutrition (한국식품영양과학회)
권호 표지
DOI QR코드

DOI QR Code

Oral Repeated-dose Toxicity Studies Especially in the Liver and Kidney of Rats Administered with Organic Germanium-fortified Yeasts

  • Published : 2006.06.01
Download PDF
⟨ Previous Next ⟩

Abstract

The object of this study was to examine whether the germanium fortified yeast administered to SD rat is accumulated in the liver and kidney. The administration doses were within 2,000 mg/kg which is the level of NOAEL (no observed adverse effect level) proved through the previous study of single/consecutive oral toxicity test. There were no significant clinical symptoms and mortality following the administration of organic germanium-fortified yeast (0, 500, 1,000, 2,000 mg/kg) during the whole test period, and also no difference in the consumed amount of feed and water for each group. No significant abnormalities of hematology and blood chemistry parameters were found in all groups of organic germanium-fortified yeast (0, 500, 1,000, 2,000 mg/kg). The amount of germanium accumulated in liver and kidney was 0 g/kg by ICP-AES method in the group of organic germanium-fortified yeast. In the positive control group of $GeO_2$ (150 mg/kg), the amount of accumulation was shown to 3135.0 and 4277.2 g/kg in each female and male kidney and 1044.3 and 2135.8 g/kg in each female and male liver, respectively. Organic germanium-fortified yeast, a biosynthetic product resulting from putting germanium into yeast, did not show any clinical symptoms, blood chemical significance, and residues in kidney and liver. It could be inferred that the non-toxic amount of organic germanium-fortified yeast was up to 2,000 mg/kg.

Keywords

References

  1. Tao SH, Bolger PM. 1997. Hazard assessment of germanium supplements. Regul Toxicol Pharmacol 25: 211-219 https://doi.org/10.1006/rtph.1997.1098
  2. Schauss AG. 1991. Nephrotoxicity and neurotoxicity in human from organogermanium compounds and germa-nium dioxide. Biol Trace Elem Res 29: 267-280 https://doi.org/10.1007/BF03032683
  3. Suzuki F, Brutkiewicz RR, Pollard RB. 1985. Importance of T-cells and macrophages in the antitumor activity of carboxyethylgermanium sesquioxide (Ge-132). Anticancer Res 5: 479-483
  4. Aso H, Suzuki F, Yamaguchi T, Hayashi Y, Ebina T, Ashida N. 1985. Induction of interferon and activation of NK cells and macrophages in mice by oral adminis-tration of Ge-132, and organic germanium compound. Microbiol Immunol 29: 65-74 https://doi.org/10.1111/j.1348-0421.1985.tb00803.x
  5. Hammett FS, Nowrey JE Jr, Muller JH. 1992. The erythro-poi-etic action of germanium dioxide. J Exp Med 35: 173-180 https://doi.org/10.1084/jem.35.2.173
  6. Nakada Y, Kosaka T, Kuwabara M, Tanaka S, Sato K, Koide F. 1993. Effects of 2-carboxyethylgermanium sesquioxide (Ge-132) as an immunological modifier of postsurgical immunosuppression in dogs. J Vet Med Sci 55: 795-799 https://doi.org/10.1292/jvms.55.795
  7. Sijpesteijn AK, Rukens F, Van Der Kerk GJ, Manten A. 1964. Antimicrobial activity of organogermanium derivatives. Nature 201: 736
  8. Han C, Yin WG, Shen M. 1992. Inhibition by ger-manium oxide of the mutagenicity of cadmium chloride in various genotoxicity assays. Food Chem Toxicol 30: 521-524 https://doi.org/10.1016/0278-6915(92)90104-S
  9. Lee CH, Lin RH, Liu SH, Lin-Shiau SY. 1998. Effects of germanium oxide and other chemical compounds on phenylmercury acetate-induced genotoxicity in cultured human lymphocytes. Environ Mol Mutagen 31: 157-162 https://doi.org/10.1002/(SICI)1098-2280(1998)31:2<157::AID-EM7>3.0.CO;2-J
  10. Sanai T, Okuda S, Onoyama K, Oochi N, Takaichi S, Mizuhira V, Fujishima M. 1991a. Chronic tubulointerstitial changes induced by germanium dioxide in comparison with carboxyethylgermanium sesquioxide. Kidney Int 40: 882-890 https://doi.org/10.1038/ki.1991.289
  11. Sanai T, Onoyama K, Osato S, Motomura K, Oochi N, Oh Y, Okuda S, Takaichi S, Fujishima M. 1991b. Dose dependency of germanium dioxide-induced nephrotoxicity in rats. Nephron 57: 349-354 https://doi.org/10.1159/000186286
  12. Wei XS. 1992. Effect of yeast on bioenrichment of germanium. Food Science 149: 49-54
  13. Klapcinska B, Chmielowski J. 1986. Binding of germa-nium to Pseudomonas putida cells. Appl Environ Microbiol 51: 1144-1147
  14. Lynn MR, Geoffrey MG. 1997. Mutants of Sacchromyces cerevisiae defective in vacuolar function a role for the vacuole in toxic metal ion detoxification. Microbiol Lett 152: 293-298 https://doi.org/10.1111/j.1574-6968.1997.tb10442.x
  15. Van Dyke MI, Lee H, Travors JT. 1989. Ger-manium toxicity in selected bacterial and yeast stains. J Ind Microbiol 4: 299-306 https://doi.org/10.1007/BF01577353
  16. Song WJ, Lee SC, Oh TK. 1995. Preparation of organic germanium by yeast cell. Kor J Appl Microbiol Biotechnol 23: 87-90
  17. Lee SH, Ahn SD, Rho SN, Sohn TU. 2005. A study on preparation and binding properties of germanium-fortified yeast. J Korean Soc Appl Biol Chem 48: 382-387
  18. Lee JS, Park JI, Kim SH, Park SH, Kang SK, Park CB, Sohn TU, Jang JY, Kang JK, Kim YB. 2004. Oral single and repeated-dose toxicity studies on Geranti Bio-Ge $Yeast^{\circledR}$, organic germanium fortified yeasts, in rats. J Toxicol Sci 29: 541-553 https://doi.org/10.2131/jts.29.541
  19. Sanai T, Oochi N, Okuda S, Osato S, Kiyama S, Komota T, Onoyama K, Fujishima M. 1990. Sub-acute nephrotoxicity of germanium dioxide in the exper-imental animal. Toxicol Appl Pharmacol 103: 345-354 https://doi.org/10.1016/0041-008X(90)90234-L
  20. Lee JS, Park JI, Kim SH, Park SH, Lee HY, Hwang ZZ, Park, CB, Sohn TU, Shin SH, Kang JK, Kim YB. 2004. Oral single and repeated-dose toxicity studies on Geranti Bio-Ge yeast, organic germanium-fortified yeasts, in dogs. J Toxicol Sci 29: 555-569 https://doi.org/10.2131/jts.29.555
  21. Min SJ, Zheng MS, Park JI, Lee JS, Kim YB, Kang JK, Sohn TU, Park CB. 2004. Genotoxicity studies on Geranti Bio-Ge Yeast, an organic germanium synthesized in yeasts. Korean J Lab Ani Sci 20: 81-88
  22. Matsusaka T, Fujii M, Nakano T, Terai T, Kurata A, Imaizumi M, Abe H. 1988. Germanium-induced neophro-pathy: report of two cases and review of the literature. Clinical Nephrology 30: 341-345
  23. Okada K, Okagawa K, Kawakami K, Kuroda Y, Morizumi K, Sato H, Morita H, Shimomura S, Saito S. 1989. Renal failure caused by long-term use of a germanium preparation as an elixir. Clinical Nephrology 31: 219-224
  24. Ahn DC, Choi YS, Park DH, Park SY, Han ZZ, Song IS, Kim EJ, Lee MS, Kwon MS. 2001. Chronic toxicity of dry yeast-G (biogermanium) orally administered to rats for consecutive months. Korean J Lab Anin Sci 17: 109-118
  25. Schroeder HA, Balassa JJ. 1967. Arsenic, ger-manium, tin, and vanadium in mice. Effects on growth, survical and tissue levels. J Nutr 92: 245-252 https://doi.org/10.1093/jn/92.2.245
  26. Chen Y, Wang N, Shangguan G, Chen Y. 1993. Deter-mination of germanium in urine an syudies on pharma-cokinetics of Ge-132 in body. Zhongguo Yiyuan Yaoxue Zazhi 13: 103-105
  27. Miyao K, Onishi T, Asai K, Tomizawa S, Suzuki F. 1980. Toxicology and phase I studies on a novel organogermanium compound, Ge-132. Curr Chemother Infect Dis 2: 1527- 1529

Cited by

  1. A review of public and environmental consequences of organic germanium vol.50, pp.13, 2006, https://doi.org/10.1080/10643389.2019.1661175